Cargando…
免疫抑制治疗后合并血流感染的重型再生障碍性贫血患者临床特征及预后分析
OBJECTIVE: To assess the clinical feature and outcomes of severe aplastic anemia (SAA) patients suffered from bacteremia following antithymocyte globulin (ATG). METHODS: A total of 264 cases hospitalized in our hospital between Jan 2000 and July 2011 were enrolled into this study. We evaluated the a...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342111/ https://www.ncbi.nlm.nih.gov/pubmed/27719726 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.09.015 |
Ejemplares similares
-
重型/极重型再生障碍性贫血患者免疫抑制治疗后早期死亡的临床特征及预测模型构建
Publicado: (2022) -
免疫抑制治疗后三个月未获血液学反应的重型/极重型再生障碍性贫血患者六个月疗效评估
Publicado: (2022) -
重型再生障碍性贫血免疫抑制治疗疗效预测及治疗展望
Publicado: (2020) -
难治/复发重型再生障碍性贫血23例二次免疫抑制治疗临床分析
Publicado: (2020) -
重型再生障碍性贫血免疫抑制治疗迟发血液学反应研究
Publicado: (2016)